174 related articles for article (PubMed ID: 33342359)
1. Metastatic TNBC is closely associated with a fused mitochondrial morphology and a glycolytic and lipogenic metabolism.
Pérez-Treviño P; Aguayo-Millán CD; Santuario-Facio SK; Vela-Guajardo JE; Salazar E; Camacho-Morales A; Ortiz R; García N
Biochem Cell Biol; 2021 Aug; 99(4):447-456. PubMed ID: 33342359
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
[TBL] [Abstract][Full Text] [Related]
4. Aggressive triple negative breast cancers have unique molecular signature on the basis of mitochondrial genetic and functional defects.
Guha M; Srinivasan S; Raman P; Jiang Y; Kaufman BA; Taylor D; Dong D; Chakrabarti R; Picard M; Carstens RP; Kijima Y; Feldman M; Avadhani NG
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1060-1071. PubMed ID: 29309924
[TBL] [Abstract][Full Text] [Related]
5. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.
Rossi T; Zamponi R; Chirico M; Pisanu ME; Iorio E; Torricelli F; Gugnoni M; Ciarrocchi A; Pistoni M
J Exp Clin Cancer Res; 2023 Jan; 42(1):7. PubMed ID: 36604676
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer.
Wang Y; Harada-Shoji N; Kitamura N; Yamazaki Y; Ebata A; Amari M; Watanabe M; Miyashita M; Tada H; Abe T; Suzuki T; Gonda K; Ishida T
Cancer Med; 2024 Jan; 13(2):e6987. PubMed ID: 38334464
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback loop between mitochondrial fission and Notch signaling promotes survivin-mediated survival of TNBC cells.
Chen L; Zhang J; Lyu Z; Chen Y; Ji X; Cao H; Jin M; Zhu J; Yang J; Ling R; Xing J; Ren T; Lyu Y
Cell Death Dis; 2018 Oct; 9(11):1050. PubMed ID: 30323195
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes.
Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A
FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636
[TBL] [Abstract][Full Text] [Related]
9. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.
Hu J; Zhang Y; Jiang X; Zhang H; Gao Z; Li Y; Fu R; Li L; Li J; Cui H; Gao N
J Exp Clin Cancer Res; 2019 May; 38(1):225. PubMed ID: 31138329
[TBL] [Abstract][Full Text] [Related]
10. RGCC-mediated PLK1 activity drives breast cancer lung metastasis by phosphorylating AMPKα2 to activate oxidative phosphorylation and fatty acid oxidation.
Cheng S; Wan X; Yang L; Qin Y; Chen S; Liu Y; Sun Y; Qiu Y; Huang L; Qin Q; Cui X; Wu M; Liu M
J Exp Clin Cancer Res; 2023 Dec; 42(1):342. PubMed ID: 38102722
[TBL] [Abstract][Full Text] [Related]
11. SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Huang S; Hu X; Liu S; Wu J; Shao ZM; Jin W
Cancer Res; 2016 Feb; 76(4):952-64. PubMed ID: 26676758
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer.
Weiner-Gorzel K; Murphy M
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188518. PubMed ID: 33545296
[TBL] [Abstract][Full Text] [Related]
13. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
14. Studying the Metabolism of Epithelial-Mesenchymal Plasticity Using the Seahorse XFe96 Extracellular Flux Analyzer.
Bhatia S; Thompson EW; Gunter JH
Methods Mol Biol; 2021; 2179():327-340. PubMed ID: 32939731
[TBL] [Abstract][Full Text] [Related]
15. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract][Full Text] [Related]
16. Expression of metabolism-related proteins in triple-negative breast cancer.
Kim MJ; Kim DH; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(1):301-12. PubMed ID: 24427351
[TBL] [Abstract][Full Text] [Related]
17. 9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model.
Ali N; Wolf C; Kanchan S; Veerabhadraiah SR; Bond L; Turner MW; Jorcyk CL; Hampikian G
Biomed Pharmacother; 2024 Jan; 170():115997. PubMed ID: 38118350
[TBL] [Abstract][Full Text] [Related]
18. Na+/H+ exchanger NHE1 regulation modulates metastatic potential and epithelial-mesenchymal transition of triple-negative breast cancer cells.
Amith SR; Wilkinson JM; Fliegel L
Oncotarget; 2016 Apr; 7(16):21091-113. PubMed ID: 27049728
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue.
Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Philp NJ; Pestell RG; Lisanti MP
Cell Cycle; 2012 Apr; 11(7):1445-54. PubMed ID: 22395432
[TBL] [Abstract][Full Text] [Related]
20. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
